INOZYME PHARMA INC (INZY) Stock Cash Flow
NASDAQ:INZY - Nasdaq - US45790W1080 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -106.72M | -102.02M | -71.17M | -67.06M | -56.62M | |||
| Depreciation Amortization | 736.00K | 742.00K | 833.00K | 740.00K | 670.00K | |||
| Change In Working Capital | 3.12M | 4.71M | -3.08M | 2.01M | 90.00K | |||
| Interest Paid | N/A | 4.35M | N/A | N/A | N/A | |||
| Other non cash items | 6.34M | 4.66M | 2.74M | 6.54M | 7.71M | |||
| OPERATING CASH FLOW | -96.53M | -91.91M | -70.67M | -57.76M | -48.15M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -30.00K | -62.00K | -298.00K | -410.00K | -400.00K | |||
| Other Investing Activity | 90.32M | 67.06M | -53.35M | -4.99M | 43.19M | |||
| INVESTING CASH FLOW | 90.29M | 67.00M | -53.65M | -5.40M | 42.80M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 40.00M | 4.05M | N/A | |||
| Stock Issued/Repurchased | 11.47M | 11.40M | 85.97M | 68.74M | 610.00K | |||
| FINANCING CASH FLOW | 11.47M | 11.40M | 125.97M | 72.79M | 610.00K | |||
| Exchange Rate Effect | -4.00K | 4.00K | -18.00K | -30.00K | 20.00K | |||
| CHANGE IN CASH | 5.23M | -13.51M | 1.63M | 9.60M | -4.72M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -96.53M | -91.91M | -70.67M | -57.76M | -48.15M | |||
| Capital Expenditure | -30.00K | -62.00K | -298.00K | -410.00K | -400.00K | |||
| FREE CASH FLOW | -96.56M | -91.97M | -70.97M | -58.17M | -48.55M | |||
All data in USD